The Eye Drop Epidemic: A Pattern of Contamination and Negligence The recent recall of 2.
5 million bottles of eye drops by Lupin Pharmaceuticals is a stark reminder that contamination cases are not isolated incidents within the industry.
This latest recall follows a string of similar instances, including a June Class II FDA recall status for temporary adverse effects.